Become study center
If you and your institution are interested in bringing forward our innovative therapeutic approaches, and in contributing with us to this venture, you can contact us through the dedicated form on this website.
To become a study center in a clinical trial testing one of the approaches, your institution needs to have access to several facilities/competences briefly described below.
Your institution should offer a fully equipped ophthalmologic center for ocular surgery with experienced ophthalmic surgeons.
The GMP-grade production of cellular standard transplantation and Gene Therapy Medicinal products requires a clean room facility and personnel trained in genetic engineering, cell and molecular biology, as well as quality control.
The required special equipment and consumables will be the CliniporatorTM for cell electroporation, together with the corresponding microcuvettes (single-use) and the cuvette holder, electroporation buffer and the plasmid mixture.
In addition, your participation to the clinical trial has to be approved by the local ethical commission and national regulatory authorities, for which you need to prepare a full dossier.
In exchange, we will provide you support in preparing dossiers for ethical and regulatory approval, in adapting our approach to your institution, and in validating your production. We offer study protocols and related documents, SOPs (Standard Operating Procedure) about product manufacture and quality control, and training to your personnel to allow its qualification.
We will support joint grant proposal submissions to finance the realization of the trial in your institution.
The start of the first clinical study (TargetAMD 1.0) is foreseen for fall 2023 and thus, your participation would be possible at the earliest in summer 2024.